Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl citrate for procedural breakthrough pain in cancer
NCT03809455Phase 2Withdrawn
- Sponsor
- Unicancer
- Start
- Feb 2020
- Primary completion
- Feb 2022
01
Overview
A Phase 2 trial of fentanyl citrate nasal spray in breakthrough pain, sponsored by Unicancer. Planned start Feb 2020; status: withdrawn.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT03809455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809455.